Molecular insights into Kv11.1 (hERG) cardiotoxicity

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|3|940-955

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.3, 2015-02, pp. : 940-955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological and electrophysiological characterization of AZSMO‐23, an activator of the hERG K+ channel

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 12, 2015-06 ,pp. : 3112-3125

John Wiley & Sons Inc

Access to resources Recommend Favorite

SUMO co‐expression modifies KV11.1 channel activity

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 222, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanism of doxorubicin cardiotoxicity evaluated by integrating multiple molecular effects into a biophysical model

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 5, 2018-03 ,pp. : 763-781

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Mutation P.T613a in the Pore Helix of the Kv11.1 Potassium Channel is Associated with Long QT Syndrome

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 38, Iss. 11, 2015-11 ,pp. : 1304-1309

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1422-1430

John Wiley & Sons Inc

Access to resources Recommend Favorite